Nemus Bioscience Inc., of Costa Mesa, Calif., updated its private placement arrangement with Schneider Finance LLC for the sale of 1 million shares of series E preferred stock for gross proceeds of $20 million, stating that Schneider did not provide funding to close the transaction on July 10, as required under the securities purchase agreement and has requested an extension of the closing date.